by mpzzqmvj | Mar 24, 2022 | Press Releases
– Collaboration with the University of the Witwatersrand, Johannesburg (“Wits”), represented by Wits Commercial Enterprise; a wholly-owned subsidiary of the University mandated to manage and commercialize the University’s Intellectual Property;...
by mpzzqmvj | Mar 23, 2022 | Press Releases
– Live webcast fireside chat on Wednesday, March 30th at 12:30 PM ET GAINESVILLE, Fla. – Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing...
by mpzzqmvj | Mar 14, 2022 | Press Releases
– Lead development program evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 (NPC1) in ongoing pivotal study (TransportNPC™) continues to progress – Company advancing Trappsol® Cyclo™ for the treatment of...
by mpzzqmvj | Mar 10, 2022 | Press Releases
Presentation with live video webcast on Wednesday, March 16th at 3:20 PM ET GAINESVILLE, Fla. – Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to...
by mpzzqmvj | Feb 8, 2022 | Press Releases
GAINESVILLE, Fla. – Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and...
